Wellington Management Group LLP Crinetics Pharmaceuticals, Inc. Transaction History
Wellington Management Group LLP
- $545 Billion
- Q3 2025
A detailed history of Wellington Management Group LLP transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 8,381,991 shares of CRNX stock, worth $347 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
8,381,991
Previous 5,807,308
44.34%
Holding current value
$347 Million
Previous $167 Million
109.02%
% of portfolio
0.06%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding CRNX
# of Institutions
245Shares Held
91.1MCall Options Held
59.7KPut Options Held
14.8K-
Vanguard Group Inc Valley Forge, PA9.17MShares$380 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.48MShares$269 Million2.29% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$258 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA5.77MShares$239 Million1.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.31MShares$220 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.23B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...